Novel strategies for the detection of drug resistance in Mycobacterium tuberculosis
- 31 December 1996
- journal article
- editorial
- Published by Elsevier in Research in Microbiology
- Vol. 147 (1-2) , 73-79
- https://doi.org/10.1016/0923-2508(96)80207-5
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Molecular Mechanisms of Multiple Drug Resistance in Clinical Isolates of Mycobacterium tuberculosisThe Journal of Infectious Diseases, 1995
- Missense mutations in the catalase‐peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosisMolecular Microbiology, 1995
- Rapid Identification Of A Point Mutation Of The Mycobacterium tuberculosis Catalase-Peroxidase (katG) Gene Associated With Isoniazid ResistanceThe Journal of Infectious Diseases, 1995
- Molecular biology in the diagnosis and epidemiology of tuberculosisJournal of Hospital Infection, 1994
- Selection of a gyrA Mutant of Mycobacterium tuberculosis Resistant to Fluoroquinolones during Treatment with OfloxacinThe Journal of Infectious Diseases, 1994
- Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular studyThe Lancet, 1994
- inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosisScience, 1994
- Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknotMolecular Microbiology, 1993
- Antituberculosis drug screeningThe Lancet, 1993
- Detection of rifampicin-resistance mutations in Mycobacterium tuberculosisThe Lancet, 1993